Biobeat Digital Home Monitoring Feasibility
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
About this trial
To assess the feasibility of evaluating postoperative home monitoring with Biobeat digital monitoring. The investigators hypothesize that the Biobeat digital home monitoring platform will lead to a decrease in unplanned visits to the ED (Emergency Department). In addition, patients' quality of life is postulated to be improved compared to patients receiving the current standard of care without home monitoring.
Eligibility criteria
Qualifiers
Patient willing to provide informed consent
Wi-fi or cellular connectivity at the patient's home
Patient undergoing elective lung cancer surgery
Patient familiar/comfortable with the use of technology such as online banking.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Digital Group
Treatment groups
48 Participants
are divided into 2 treatment groupsSponsors and collaborators
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead sponsor
London Health Sciences Centre
Sponsor institution
Source ClinicalTrials.gov